FDA approval of a novel non-opioid analgesic will hopefully address the needs of many patients with acute pain and improve ...

MacroGenics (NASDAQ:MGNX – Free Report) had its price objective cut by HC Wainwright from $4.00 to $2.00 in a research note ...

Patients with moderate to severe Crohn’s disease who did not achieve clinical response to IV induction with Skyrizi ...

Long-term nemolizumab use reduces itch, disease severity, and steroid dependence in patients with prurigo nodularis in a ...

Equities research analysts at Scotiabank issued their FY2026 earnings per share estimates for Magna International in a research report issued to clients and investors on Wednesday, March 19th.

Recombinant human prourokinase is noninferior to alteplase in acute ischemic stroke, with symptomatic intracranial hemorrhage and major bleeding decreased.

A urine test strip method using the semi-quantitative albumin-to-creatinine ratio can enhance the early detection of chronic ...

Follow this easy high-fiber meal to plan to help promote regularity and healthy digestion. Reviewed by Dietitian Jessica Ball ...

Findings from MINT will be presented at the American Academy of Neurology Annual Meeting on April 8, 2025, in San Diego.

Luveltamab tazevibulin demonstrated activity in an ongoing phase 2/3 trial of patients with FRα-positive, platinum-resistant ovarian cancer.

Amgen AMGN reported the latest data from the phase III MINT study that evaluated the rare disease drug Uplizna (inebilizumab) ...

The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...